INSIGHTS ON CLINICAL TRIAL PARTNERING

• Five Questions Biotechs Should Ask Before Selecting A Bioanalytical CRO

  In a landscape where speed, quality, and trust are inseparable, choosing a CRO that shares your ambition is not optional; it is essential to survival and success.

• Who Is Responsible When AI Helps Write The Consent Form?

  AI is reshaping consent materials, but accuracy, oversight, and transparency remain essential. As guidance evolves, organizations must balance innovation with accountability to protect participants.

• The Clinical Trial Inefficiencies Hiding in Plain Sight

  Clinical trials are often slowed by disconnected systems. Centralizing payments, logistics, and data helps streamline operations and retain patients.

• Establishing Trust With Real People In Clinical Research

  Get actionable strategies to enhance engagement, strengthen relationships, and support study success in clinical research through clear communication, transparency, and ethical practices.

• EU Clinical Trial Regulation Timelines: Shorter Than Many Expect

  7/30/2026

  The EU CTR rewards early planning. Strong documentation, regulatory readiness, and aligned partners can help accelerate approvals and reduce delays.

• Unanticipated Roadblocks In Ovarian Cancer Drug Development

  3/9/2026

  Enhance your Ovarian cancer trials by enabling community referral pipelines, aligning imaging with biomarker assessments, and selecting sites based on verifiable surgical capacity.

• Navigating Autoimmune Disease A Playbook For Cell And Gene Therapies

  9/3/2025

  By integrating site readiness, patient engagement, and data-driven decision-making, the cell and gene therapies (CAGT) field is advancing toward therapies that not only control disease but transform lives.

• eCOA Standards And KPIs To Include In Your Next RFI

  3/9/2026

  Check out this practical roadmap on vendor selection and learn specific performance metrics and quality benchmarks you should ask your next eCOA partner.

• Use Case: A Patient-Centric Approach To Site Selection

  1/27/2025

  Discover how Citeline’s robust datasets, combined with real-world data, inform intelligent site and investigator selection for a rare, autoimmune disease.